Circulation

JANUARY 9, 2025

Cohorts were grouped into preallocation and postallocation change eras: pediatric patients from January 1, 2011, to March 21, 2016, and January 1, 2017, to December 31, 2021; and adult patients from January 1, 2015, to October 17, 2018, and January 1, 2019, to December 31, 2021.

Congenital Heart Disease 49

Congenital Heart Disease Pediatrics Cardiomyopathy Transplant 49

DAIC

APRIL 16, 2024

The key benefits of Barostim contained in the manuscript include the following: There was not a statistically significant difference in the primary endpoint of CV death and HF hospitalization, demonstrating that the benefits of the therapy do not increase the long-term risk of harm to patients Patients receiving Barostim + guideline-directed medical (..)

Heart Failure 104

Heart Failure Quality of Life Transplant Heart Transplant 104

CardiacWire

AUGUST 21, 2024

These improvements would allow the Ventura IAS to address the notable HFrEF treatment gap between GDMT and far more invasive therapies like LVAD and heart transplantation. The Ventura already has a European CE Mark, and gained FDA Breakthrough Device Designation back in 2019, although its still working towards FDA approval.

Heart Transplant 64

Heart Transplant Heart Failure Interventional Cardiology Transplant 64

Circulation

NOVEMBER 11, 2024

Heart transplant rates were low but increased slightly in 2020 for patients without CHD, with DV and SV CHD patients showing fluctuating rates peaking in 2018 and 2019, then declining in 2020.

Cardiogenic Shock 40

Cardiogenic Shock Congenital Heart Disease Heart Failure Congenital 40

Circulation: Heart Failure

DECEMBER 10, 2024

Circulation: Heart Failure, Ahead of Print. BACKGROUND:Cardiac allograft vasculopathy (CAV) leads to impaired myocardial blood flow (MBF), increasing the risk of cardiovascular death or retransplant among heart transplantation (HT) recipients.

Coronary Angiogram 40

Coronary Angiogram Heart Transplant Heart Failure Transplant 40

Circulation: Heart Failure

MARCH 8, 2024

Centers performing at least 1 heart transplant or left ventricular assist device were classified as ATCs. Patient characteristics, outcomes, and procedural volume were compared among 3 cohorts: admissions to non-ATCs, admissions to ATCs, and transfers to ATCs.

Heart Failure 40

Heart Failure Cardiogenic Shock Outcomes Cardiac Arrest 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 17, 2023

Methods A retrospective study was conducted on 468 patients who underwent ablation for CTI dependent typical AFL at a single institution between 2010 and 2019. Echocardiographic data were analyzed at baseline before ablation, and at early follow-up within 1-year postablation.

Atrial Flutter 40

Atrial Flutter Ablation Heart Transplant Tricuspid 40